✦ LIBER ✦

A Phase I Trial of Daily Oral 4′-N-Benzoyl-Staurosporine in Combination with Protracted Continuous Infusion 5-Fluorouracil in Patients with Advanced Solid Malignancies

✍ Scribed by Joseph P. Eder; Rocio Garcia-Carbonero; Jeffrey W. Clark; Jeffrey G. Supko; Thomas A. Puchalski; David P. Ryan; Pamela Deluca; Antoinette Wozniak; Angela Campbell; John Rothermel; Patricia LoRusso

Book ID: 111579893
Publisher: Springer US
Year: 2004
Tongue: English
Weight: 139 KB
Volume: 22
Category: Article
ISSN: 0167-6997
DOI: 10.1023/b:drug.0000011790.31292.ef

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Raltitrexed combined with 5-fluorouracil

Raltitrexed combined with 5-fluorouracil continuous infusion: a phase I/II dose-escalation trial in advanced solid tumors

✍ Massuti, B.; Sastre, J.; Aranda, E.; Tabernero, J.; Cajal, R.; García de Paredes 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Phase I trial of a 5-day infusion ofL-le

Phase I trial of a 5-day infusion ofL-leucovorin plus daily bolus 5-fluorouracil in patients with advanced gastrointestinal malignancies

✍ Frank H. Valone; David R. Gandara; Judith A. Luce; Susan Wall; Edith A. Perez; N 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 647 KB

Phase I dose finding study of irinotecan

Phase I dose finding study of irinotecan (CPT-11) over a short i.v. infusion combined with a fixed dose of 5-fluorouracil (5-FU) protracted continuous i.v. infusion in patients with advanced solid tumours

✍ Sastre, J.; Paz-Ares, L.; Díaz-Rubio, E.; Cortés-Funes, H.; Carcas, A.; Gruia, G 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 247 KB

A phase I trial of cisplatin in hyperton

A phase I trial of cisplatin in hypertonic saline and escalating doses of 5-fluorouracil by continuous intravenous infusion in patients with advanced malignancies

✍ Leonard Saltz; David Kelsen 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 427 KB 👁 2 views

A phase I, dose-finding study of irinote

A phase I, dose-finding study of irinotecan (CPT-11) short i.v. infusion combined with fixed dose of 5-fluorouracil (5-FU) protracted i.v. infusion in adult patients with advanced solid tumours

✍ Javier Sastre; Luis Paz-Ares; Antonio Carcas; Rosario Alfonso; Cristina Grávalos 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 299 KB

A phase II trial of weekly high dose con

A phase II trial of weekly high dose continuous infusion 5-fluorouracil plus oral leucovorin in patients with advanced colorectal cancer

✍ Enrique Aranda; Andrés Cervantes; Javier Dorta; Esperanza Blanco; Carlos Fernánd 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB 👁 2 views

Background. In a previous Phase I1 trial, the authors showed that a weekly continuous infusion of 5-fluorouracil (5-FU) at a dose of 3.5 g/mz for 48 hours is an active treatment for advanced colorectal cancer. The overall response rate was 38.5%, and the median survival was 12 months. These data wer